The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma

BACKGROUND: Esophageal cancer is a common gastrointestinal malignancy in China. We evaluated the efficacy and safety of adding Apatinib to concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. MATERIAL/METHODS: In this single-center retrospective study, w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Hu, Lijun, Kong, Ze, Meng, Qinghong, Wang, Jianlin, Zhou, Mengyun, Yu, Jingping, Jiang, Xiaodong
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7706142/
https://ncbi.nlm.nih.gov/pubmed/33243967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.927221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars